APAC Ashwagandha Market - Industry Trends And Forecast To 2030
The Asia-Pacific ashwagandha market is expected to reach USD 36,617.60 thousand in 2030 from USD 15,927.03 thousand in 2022, growing at a CAGR of 11.1% in the forecast period of 2023 to 2030.
Market Segmentation:Asia-Pacific Ashwagandha Market, By Type (KSM-66, Sensoril, Hydro-Alcoholic Ashwagandha, Crude Ashwagandha, and Others, Product Type (Ashwagandha Root Product, Ashwagandha Leaf Products, and Ashwagandha Leaf and Root Mix Product), Withanolides Content (1% Withanolides, 3 2% Withanolides, 2.5% Withanolides, 5% Withanolides, 10% Withanolides, and Others), Category (Regular, and Full Spectrum), Form (Powder, Capsule, and Liquid), Function (Improved Stamina, Improved Immunity, Overall Wellbeing, Reduced Anxiety and Stress, Brain Health, Muscle Strength, and Others), and Application (Food & Beverages, Pharmaceutical, Dietary Supplements, Sports Nutrition, and Others), (India, China, Japan, Australia, South Korea, Singapore, Thailand, Indonesia, Taiwan, Hong Kong, Malaysia, New Zealand, Philippines, and Rest of Asia-Pacific) - Industry Trends and Forecast To 2030.
Overview of Asia-Pacific Ashwagandha Market Dynamics:Driver
• Rapidly increase in demand for ashwagandha supplements
Restraint
• Less awareness regarding the benefits of ashwagandha
Opportunity
• Rapidly growing adoption of ayurvedic medicines
Market Players:Some of the major players operating in the Asia-Pacific ashwagandha market are:• KSM66 Ashwagandha (Ixoreal Biomed)
• Sami-Sabinsa Group
• Dabur India Limited (2022)
• Himalaya Wellness Company
• Swanson
• Zanducare (A Subsidiary of Emami Ltd.)
• Patanjali Ayurved
• Herbochem
• Apex International
• Kerry Group plc (2022)
• Kairali Ayurvedic Products
• Bioprex Labs
• Natreon Inc.
• Medikonda Nutrients
• Carrubba. Inc
• Organic India Pvt. Ltd.
• Zoic Pharmaceuticals.
• Creative Enzymes
• Aunutra Industries Inc.